Key result
High soluble transferrin receptor is linked to ~4.2-fold higher 5-year mortality in diabetic CAD patients.
Cohort (n=287)
Answers are grounded in this paper and cite their sources.
OBJECTIVE: To investigate the impact of iron status on survival in patients with type 2 diabetes and coronary artery disease (CAD). RESEARCH DESIGN AND METHODS: Serum ferritin, transferrin saturation (Tsat), and soluble transferrin receptor (sTfR) were measured in 287 patients with type 2 diabetes and stable CAD (65 ± 9 years of age, 78% men). RESULTS: During a mean follow-up of 45 ± 19 months, there were 59 (21%) deaths and 60 (21%) cardiovascular hospitalizations. Both serum ferritin and sTfR strongly predicted 5-year all-cause mortality rates, independently of other variables (including hemoglobin, measures of renal function, inflammation, and neurohormonal activation). There was an exponential relationship between sTfR and mortality (adjusted hazard ratio [HR] per 1 log mg/L: 4.24 [95% CI 1.43-12.58], P = 0.01), whereas the relationship between ferritin and mortality was U-shaped (for the lowest and the highest quintiles vs. the middle quintile [reference group], respectively: adjusted HR 7.18 [95% CI 2.03-25.46], P = 0.002, and adjusted HR 5.12 [1.48-17.73], P = 0.01). Similar patterns were observed for the composite outcome of all-cause mortality or cardiovascular hospitalization, and in these multivariable models, low Tsat was related to unfavorable outcome. CONCLUSIONS: Both low and high serum ferritin (possibly reflecting depleted and excessive iron stores, respectively) along with high serum sTfR (reflecting reduced metabolically available iron) identify patients with type 2 diabetes and CAD who have a poor prognosis.
No takes yet. Share an insight, caveat, or question.
Ponikowska et al. (2013) conducted a cohort in Type 2 diabetes and stable coronary artery disease (n=287). Iron status biomarkers (serum ferritin, soluble transferrin receptor [sTfR], transferrin saturation [Tsat]) vs. Middle quintile of serum ferritin (reference group) or lower sTfR levels was evaluated on 5-year all-cause mortality (HR 4.24, 95% CI 1.43-12.58, p=0.01). High soluble transferrin receptor and low or high ferritin independently predicted 5-year mortality in diabetic CAD patients.
Synapse has enriched 10 related papers. Consider them for comparative context: